Abstract
Objective: To explore the correlation between the biological effects of P53 mutant and P53 wild-type in triple-negative breast cancer (TNBC) with dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) signs, semi-quantitative parameters, and quantitative parameters. Methods: A retrospective analysis was conducted on 68 patients (48 P53-mutant, 20 P53-wild-type). Differences were compared across MRI signs, semi-quantitative parameters (SER, $E_{peak}$, TTP, etc.), and quantitative parameters ($K^{trans}$, $K_{ep}$, $V_e$). Results: TNBC-P53 mutants showed significant differences in intratumoral T2WI high signal, early ring enhancement, $E_{peak}$, TTP, $K^{trans}$, and $K_{ep}$ ($P < 0.05$). Binary logistic regression identified TTP and $K^{trans}$ as the most effective predictors of mutation status. Conclusion: Specific DCE-MRI features are significantly correlated with P53 gene mutations in TNBC.
Introduction
Triple-Negative Breast Cancer (TNBC) is a highly aggressive subtype characterized by the absence of estrogen, progesterone, and HER2 receptors. Mutations in the P53 tumor suppressor gene occur in up to 80% of TNBC cases, driving rapid tumor growth, chaotic angiogenesis, and chemotherapy resistance. Currently, determining P53 status requires invasive biopsies, which may not capture the full heterogeneity of the tumor. This study investigates whether Dynamic Contrast-Enhanced MRI (DCE-MRI) can serve as a non-invasive "virtual biopsy" to identify these critical genetic mutations.
Methods
The study analyzed 68 TNBC patients treated at Baotou Cancer Hospital between December 2022 and August 2024. All cases were confirmed via needle biopsy and formal P53 gene testing. Using a 1.5T MRI scanner, researchers evaluated three categories of features:
- Qualitative MRI Signs: Including lesion morphology, T2-weighted signal intensity, and enhancement patterns.
- Semi-quantitative Parameters: Derived from the Time-Intensity Curve (TIC), such as Maximum Enhancement ($E_{peak}$) and Time to Peak (TTP).
- Quantitative Parameters: Pharmacokinetic modeling of contrast movement, specifically $K^{trans}$ (volume transfer constant) and $K_{ep}$ (rate constant).
Results: Qualitative MRI Signs
The study identified a distinct "necrosis signature" in P53-mutant tumors. Due to rapid growth outstripping blood supply, mutant tumors frequently exhibited internal necrosis, appearing as high T2-weighted signals and characteristic "ring enhancement."
Statistically, 89.6% of mutants showed high T2WI signals compared to 65% of wild-types. Ring enhancement was also significantly more prevalent in the mutant group (79.2% vs. 55%).
Results: Quantitative and Semi-quantitative Parameters
Quantitative analysis revealed that mutant tumors possess more aggressive microvasculature. The $K^{trans}$ value for mutants was significantly higher (1.91 ± 0.11) compared to wild-types (1.71 ± 0.10), indicating leakier vessels. Furthermore, the mutant group reached maximum enhancement much faster (shorter TTP), suggesting a high density of microvessels.
Diagnostic accuracy was high for these biomarkers:
- Time to Peak (TTP): Achieved an Area Under the Curve (AUC) of 0.913.
- $K^{trans}$: Achieved an AUC of 0.888.
Discussion and Conclusion
The correlation between P53 mutations and specific DCE-MRI features—particularly shorter TTP and higher $K^{trans}$—provides a promising path for non-invasive genetic profiling. While the study is limited by a relatively small sample size (n=68) and manual ROI delineation, the high diagnostic accuracy suggests that DCE-MRI can effectively reflect the biological aggressiveness of P53-mutant TNBC. Future work will focus on expanding the cohort and implementing AI-assisted measurement to refine these imaging biomarkers for clinical use.
Summary updated